Virtuix VR Platform Used in Autism and Neurodivergent Therapy Research

May 21, 2026

Virtuix Holdings (NASDAQ: VTIX) announced that Rutgers University has deployed the company’s OmniOne omnidirectional VR treadmill platform at WinLab for advanced research involving AI-assisted neurodivergent therapy and immersive behavioral analytics, including autism therapy for children.

The initiative will explore how combining immersive virtual environments, adaptive AI interaction, and full-body movement may improve engagement and learning outcomes compared to traditional therapy approaches that rely primarily on visual and audio interaction.

#Virtuix
#VTIX
#VirtualReality
#Autism
#Neurodivergent
#AI
#Therapy
#BehavioralAnalytics
#HealthcareInnovation
#ImmersiveTech
#VRTechnology
#ArtificialIntelligence
#RutgersUniversity
#JaneKing
#NewsOut